2.4 Excretion

Excretion is a vital process in toxicology, involving the removal of toxins and their metabolites from the body. Various organs contribute to this process, including the kidneys, liver, lungs, skin, and mammary glands. Understanding excretion mechanisms is crucial for assessing toxicity risks.

Toxins can be excreted through passive diffusion, active transport, or facilitated diffusion. The kidneys play a major role in excreting water-soluble toxins, while the liver handles lipophilic toxins. Factors like physicochemical properties, protein binding, and biotransformation affect excretion rates and routes.

Excretion of toxins

• Excretion is a critical process in toxicology that involves the removal of toxins and their metabolites from the body
• Various organs and systems contribute to the excretion of toxins, including the kidneys, liver, lungs, skin, and mammary glands
• Understanding the mechanisms and factors affecting excretion is essential for assessing the toxicity and risk of exposure to various substances

Mechanisms of excretion

Top images from around the web for Mechanisms of excretion

• 

  Facilitated diffusion - Wikipedia View original

  Is this image relevant?

• 

  Passive Transport: Facilitated Transport – Principles of Biology View original

  Is this image relevant?

• 

  Passive Transport: Facilitated Transport – MHCC Biology 112: Biology for Health Professions View original

  Is this image relevant?

• 

  Facilitated diffusion - Wikipedia View original

  Is this image relevant?

• 

  Passive Transport: Facilitated Transport – Principles of Biology View original

  Is this image relevant?

1 of 3

Top images from around the web for Mechanisms of excretion

• 

  Facilitated diffusion - Wikipedia View original

  Is this image relevant?

• 

  Passive Transport: Facilitated Transport – Principles of Biology View original

  Is this image relevant?

• 

  Passive Transport: Facilitated Transport – MHCC Biology 112: Biology for Health Professions View original

  Is this image relevant?

• 

  Facilitated diffusion - Wikipedia View original

  Is this image relevant?

• 

  Passive Transport: Facilitated Transport – Principles of Biology View original

  Is this image relevant?

1 of 3

• Toxins can be excreted through various mechanisms, including passive diffusion, active transport, and facilitated diffusion
• Passive diffusion occurs when toxins move from an area of high concentration to an area of low concentration without requiring energy (oxygen, carbon dioxide)
• Active transport involves the use of energy-dependent transporters to move toxins against their concentration gradient (organic anions, cations)
• Facilitated diffusion utilizes carrier proteins to transport toxins across membranes without requiring energy (glucose, amino acids)

Excretion via kidneys

• The kidneys play a major role in the excretion of water-soluble toxins and their metabolites
• Toxins are filtered from the blood by the glomeruli and then secreted or reabsorbed by the renal tubules
• The rate of excretion via the kidneys depends on factors such as blood flow, glomerular filtration rate, and tubular secretion and reabsorption
• Examples of toxins excreted primarily via the kidneys include heavy metals (cadmium, lead) and certain drugs (aminoglycosides, cisplatin)

Excretion via liver

• The liver is responsible for the biotransformation and excretion of lipophilic toxins and their metabolites
• Toxins are metabolized by hepatic enzymes (cytochrome P450) and conjugated with polar molecules (glucuronic acid, sulfuric acid) to increase their water solubility
• The resulting conjugates are then excreted into the bile and eliminated from the body via the feces
• Examples of toxins excreted primarily via the liver include polycyclic aromatic hydrocarbons (benzo[a]pyrene) and certain drugs (acetaminophen, morphine)

Excretion via lungs

• The lungs are involved in the excretion of volatile toxins and gases
• Toxins diffuse from the blood into the alveoli and are exhaled during respiration
• The rate of excretion via the lungs depends on factors such as the solubility and partial pressure of the toxin in the blood and alveolar air
• Examples of toxins excreted primarily via the lungs include organic solvents (toluene, xylene) and anesthetic gases (nitrous oxide, sevoflurane)

Excretion via skin

• The skin can excrete certain toxins through sweat and sebaceous glands
• Lipophilic toxins can be absorbed by the skin and then excreted in sweat or sebum
• The rate of excretion via the skin is generally low compared to other routes but can be significant for certain toxins
• Examples of toxins excreted via the skin include heavy metals (arsenic, mercury) and certain drugs (methadone, fentanyl)

Excretion via mammary glands

• Toxins can be excreted in breast milk, potentially exposing nursing infants to harmful substances
• Lipophilic toxins tend to accumulate in breast milk due to their affinity for the high fat content
• The excretion of toxins via mammary glands is a concern for lactating women exposed to environmental pollutants or taking certain medications
• Examples of toxins excreted in breast milk include persistent organic pollutants (PCBs, dioxins) and certain drugs (antidepressants, chemotherapeutic agents)

Factors affecting excretion

Physicochemical properties of toxins

• The physicochemical properties of toxins, such as molecular weight, lipophilicity, and ionization, can significantly influence their excretion
• Lipophilic toxins tend to be excreted more slowly than hydrophilic toxins due to their tendency to accumulate in fatty tissues
• Ionized toxins are more readily excreted by the kidneys, while non-ionized toxins are more likely to be excreted via the liver and bile
• The molecular weight of a toxin can affect its filtration by the glomeruli and secretion by the renal tubules

Protein binding of toxins

• Many toxins bind to plasma proteins, such as albumin and alpha-1-acid glycoprotein, which can affect their distribution and excretion
• Protein-bound toxins are less likely to be filtered by the glomeruli or cross cell membranes, leading to slower excretion rates
• The extent of protein binding can vary depending on the toxin and the individual's plasma protein concentrations
• Competition for protein binding sites can occur between toxins and other endogenous or exogenous substances, potentially altering their excretion

Biotransformation of toxins

• Biotransformation, or metabolism, of toxins can greatly influence their excretion by altering their physicochemical properties
• Phase I reactions (oxidation, reduction, hydrolysis) can make toxins more or less water-soluble, affecting their excretion routes
• Phase II reactions (conjugation) generally increase the water solubility of toxins, facilitating their excretion via the kidneys or bile
• Genetic variations in biotransformation enzymes can lead to differences in the rate and extent of toxin excretion among individuals

Genetic variations in excretion

• Genetic polymorphisms in transporters and enzymes involved in excretion can lead to interindividual differences in toxin elimination
• Variations in the expression or function of renal transporters (organic anion transporters, P-glycoprotein) can affect the secretion and reabsorption of toxins
• Polymorphisms in hepatic enzymes (UDP-glucuronosyltransferases, glutathione S-transferases) can influence the conjugation and excretion of toxins via the bile
• Genetic differences in excretion pathways can contribute to variations in susceptibility to toxicity among individuals

Age and excretion

• Age can significantly impact the efficiency of excretion pathways, particularly in the very young and the elderly
• Infants and young children have immature renal and hepatic functions, leading to slower excretion rates and increased susceptibility to toxicity
• In the elderly, declining renal function and reduced hepatic blood flow can impair the excretion of toxins, leading to prolonged exposure and higher risk of adverse effects
• Age-related changes in body composition (reduced muscle mass, increased fat content) can also affect the distribution and excretion of toxins

Disease states and excretion

• Various disease states can impair the excretion of toxins, leading to their accumulation and potential toxicity
• Renal diseases (acute kidney injury, chronic kidney disease) can reduce glomerular filtration and tubular secretion, slowing the elimination of water-soluble toxins
• Hepatic diseases (cirrhosis, hepatitis) can impair the biotransformation and biliary excretion of lipophilic toxins, leading to their accumulation
• Cardiovascular diseases can reduce blood flow to the kidneys and liver, affecting the delivery and elimination of toxins
• Respiratory diseases can impair the excretion of volatile toxins and gases via the lungs

Toxicokinetics of excretion

Absorption, distribution, metabolism, excretion (ADME)

• The toxicokinetics of excretion is part of the ADME process, which describes the fate of a substance within the body
• Absorption refers to the entry of a toxin into the systemic circulation from the site of exposure (ingestion, inhalation, dermal contact)
• Distribution involves the transport of a toxin from the bloodstream to various tissues and organs, influenced by factors such as blood flow and tissue affinity
• Metabolism, or biotransformation, can alter the physicochemical properties of a toxin, affecting its distribution and excretion
• Excretion is the final step in the ADME process, involving the elimination of the toxin and its metabolites from the body

Elimination half-life of toxins

• The elimination half-life ($t_{1/2}$) is the time required for the concentration of a toxin in the body to be reduced by 50%
• The elimination half-life depends on the clearance and volume of distribution of the toxin, as described by the equation: $t_{1/2} = \frac{0.693 \times V_d}{CL}$
• Toxins with shorter elimination half-lives are excreted more rapidly, while those with longer half-lives may accumulate in the body with repeated exposure
• The elimination half-life can vary widely among toxins, ranging from minutes (nicotine) to years (persistent organic pollutants)

Clearance of toxins

• Clearance (CL) is the volume of blood or plasma cleared of a toxin per unit time, reflecting the efficiency of excretion
• Total clearance is the sum of clearances by individual organs, such as renal clearance (CLr), hepatic clearance (CLh), and others
• Renal clearance depends on glomerular filtration, tubular secretion, and reabsorption, and can be estimated using the equation: $CL_r = \frac{U \times V}{P}$, where U is the urine concentration, V is the urine flow rate, and P is the plasma concentration
• Hepatic clearance is influenced by blood flow, protein binding, and intrinsic clearance (metabolism and biliary excretion)

Bioaccumulation of toxins

• Bioaccumulation occurs when the rate of absorption of a toxin exceeds its rate of excretion, leading to an increase in body burden over time
• Lipophilic and persistent toxins are more likely to bioaccumulate due to their tendency to partition into fatty tissues and resist biotransformation and excretion
• Bioaccumulation can occur within an individual (over the lifespan) or across trophic levels in the food chain (biomagnification)
• The extent of bioaccumulation depends on factors such as the toxin's physicochemical properties, the duration and frequency of exposure, and the organism's excretion capabilities

Excretion-related toxicities

Nephrotoxicity

• Nephrotoxicity refers to the adverse effects of toxins on the kidneys, which can impair their excretory function
• Toxins can cause acute kidney injury by inducing vasoconstriction, direct tubular damage, or intratubular obstruction
• Chronic exposure to nephrotoxins can lead to progressive kidney damage, glomerulosclerosis, and chronic kidney disease
• Examples of nephrotoxins include heavy metals (cadmium, mercury), drugs (aminoglycosides, NSAIDs), and environmental pollutants (aristolochic acid)

Hepatotoxicity

• Hepatotoxicity refers to the adverse effects of toxins on the liver, which can impair its role in biotransformation and excretion
• Toxins can cause acute liver injury through various mechanisms, such as oxidative stress, mitochondrial dysfunction, and immune-mediated reactions
• Chronic exposure to hepatotoxins can lead to liver fibrosis, cirrhosis, and liver failure
• Examples of hepatotoxins include alcohol, drugs (acetaminophen, isoniazid), and environmental pollutants (aflatoxins, PCBs)

Pulmonary toxicity

• Pulmonary toxicity refers to the adverse effects of toxins on the lungs, which can impair their excretory function for volatile substances
• Inhaled toxins can cause acute lung injury by inducing inflammation, oxidative stress, and alveolar-capillary barrier disruption
• Chronic exposure to pulmonary toxins can lead to interstitial lung diseases, fibrosis, and respiratory failure
• Examples of pulmonary toxins include cigarette smoke, asbestos, and air pollutants (ozone, particulate matter)

Dermal toxicity

• Dermal toxicity refers to the adverse effects of toxins on the skin, which can impair its excretory function for certain substances
• Toxins can cause acute skin irritation, allergic reactions, or corrosion upon contact
• Chronic exposure to dermal toxins can lead to skin sensitization, dermatitis, or skin cancer
• Examples of dermal toxins include heavy metals (nickel, chromium), solvents (benzene, toluene), and certain plants (poison ivy, poison oak)

Methods to enhance excretion

Dialysis

• Dialysis is a medical procedure that can be used to remove toxins from the blood when the kidneys are unable to do so effectively
• Hemodialysis involves the circulation of blood through a semipermeable membrane, allowing the removal of water-soluble toxins and excess fluid
• Peritoneal dialysis uses the peritoneal membrane as a natural filter, with a dialysate solution introduced into the abdominal cavity to remove toxins
• Dialysis can be life-saving in cases of severe toxicity or overdose, but it is not effective for all toxins and may have side effects

Hemoperfusion

• Hemoperfusion is a technique that involves passing blood through an adsorbent cartridge to remove toxins
• The adsorbent material, such as activated charcoal or resins, binds to the toxins, effectively removing them from the circulation
• Hemoperfusion can be more effective than dialysis for certain lipophilic or protein-bound toxins
• However, hemoperfusion can also remove essential substances from the blood and may cause thrombocytopenia or coagulopathy

Chelation therapy

• Chelation therapy involves the administration of chelating agents that bind to metal ions, forming stable complexes that can be excreted in the urine
• Common chelating agents include dimercaprol (BAL), ethylenediaminetetraacetic acid (EDTA), and succimer (DMSA)
• Chelation therapy is primarily used for the treatment of heavy metal poisoning, such as lead, mercury, or arsenic toxicity
• The choice of chelating agent depends on the specific metal and the route of administration, and close monitoring is required to avoid adverse effects

Forced diuresis

• Forced diuresis is a method of increasing urine output to enhance the excretion of water-soluble toxins
• This is typically achieved by administering intravenous fluids and diuretics, such as furosemide or mannitol
• Forced diuresis can be useful for toxins that are primarily excreted unchanged in the urine, such as lithium or certain pesticides
• However, forced diuresis can also cause electrolyte imbalances, volume depletion, or pulmonary edema, and should be used with caution

Excretion in risk assessment

Excretion data in toxicology studies

• Excretion data from toxicology studies are essential for understanding the kinetics and potential risks of toxins
• In vivo studies in animals can provide information on the routes, rates, and extent of excretion for different doses and exposure scenarios
• In vitro studies using cell lines or tissue preparations can help elucidate the mechanisms of excretion and identify potential species differences
• Human clinical studies, when ethically feasible, can provide the most relevant excretion data for risk assessment purposes

Excretion in physiologically based pharmacokinetic (PBPK) modeling

• PBPK modeling is a computational approach that integrates physiological, biochemical, and physicochemical data to predict the ADME of a substance
• Excretion parameters, such as renal and hepatic clearance, are key components of PBPK models
• PBPK models can be used to simulate the excretion of a toxin under different exposure scenarios, accounting for factors such as route, dose, and duration
• These models can help refine risk assessments by providing more accurate predictions of internal dose and potential toxicity

Excretion in setting exposure limits

• Excretion data are used in the derivation of exposure limits, such as acceptable daily intakes (ADIs) or tolerable daily intakes (TDIs)
• These limits are typically based on the no-observed-adverse-effect level (NOAEL) or the benchmark dose (BMD) from animal studies, with the application of uncertainty factors
• The rate and extent of excretion can influence the choice of uncertainty factors, as toxins with slower excretion may require larger safety margins
• Excretion data can also inform the selection of biomarkers for monitoring exposure and assessing compliance with exposure limits

Excretion in drug development

Excretion in drug design

• Consideration of excretion pathways is crucial in the design of new drugs to optimize their pharmacokinetic properties and minimize toxicity
• Drug molecules can be designed to favor certain excretion routes, such as renal elimination for drugs targeting the urinary tract
• Structural modifications can be made to improve the water solubility or reduce the protein binding of a drug, enhancing its excretion
• Prodrugs can be designed to undergo biotransformation into more readily excreted active compounds

Excretion in drug safety assessment

• Excretion studies are a key component of drug safety assessment during preclinical and clinical development
• In vitro assays using hepatocytes or renal proximal tubule cells can screen for potential excretion-related toxicities
• In vivo studies in animals can evaluate the exc